AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

GEIGER COUNTER LIMITED

Share Issue/Capital Change May 12, 2020

7665_rns_2020-05-12_33d56f36-2d2c-461d-8ce0-c70bc93986c0.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 6283M

Geiger Counter Ltd

12 May 2020

12 May 2020

GEIGER COUNTER LIMITED

(THE "COMPANY")

Issue of Ordinary Shares

The Company announces that, conditional only on Admission becoming effective, it has allotted, by way of a new issue in response to market demand, 5,250,000 new ordinary shares of no par value (the "New Shares") for cash, at a price of 17.40p per share, a premium to the Company's net asset value. The New Shares will rank pari passu with the existing ordinary shares.

Applications will be made for the New Shares to be admitted to The International Stock Exchange's Listing and to trading on the London Stock Exchange's SETSqx platform ("Admission"). Admission is expected to become effective, and dealings in the New Shares are expected to commence, at 8.00 a.m. on 18 May 2020.

Following the issue of the New Shares, the Company's issued share capital will consist of 90,601,611 ordinary shares and 37,420,104 subscription shares, none of which are held in treasury.

Enquiries

CQS (UK) LLP Craig Cleland T: +44 (0) 20 7201 5368
finnCap Limited William Marle/Giles Rolls T: +44 (0) 20 7220 0500
R&H Fund Services (Jersey) Limited Jane De Barros-Sousa T :+44 (0) 1534 825 259

Important Information

The information contained in this announcement does not constitute an offer of securities for sale in any jurisdiction.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

IOEKKBBKCBKKOPD

Talk to a Data Expert

Have a question? We'll get back to you promptly.